{
  "id": "7ccaf5428f85fe5f",
  "title": "Congress Reauthorizes the Rare Pediatric Disease Priority Review Voucher Program and Clarifies Orphan Drug Exclusivity | Wilson Sonsini Goodrich & Rosati",
  "description": "20260211T194500Z",
  "content": "",
  "source": "jdsupra.com",
  "source_url": "https://www.jdsupra.com/legalnews/congress-reauthorizes-the-rare-9125713/",
  "published_at": "20260211T194500Z",
  "fetched_at": "2026-02-12T00:28:38.246764+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.jdsupra.com/legalnews/congress-reauthorizes-the-rare-9125713/",
    "url_mobile": "",
    "title": "Congress Reauthorizes the Rare Pediatric Disease Priority Review Voucher Program and Clarifies Orphan Drug Exclusivity | Wilson Sonsini Goodrich & Rosati",
    "seendate": "20260211T194500Z",
    "socialimage": "https://jdsupra-static.s3.amazonaws.com/profile-images/og.7499_58.jpg",
    "domain": "jdsupra.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}